序号 |
题名 |
广东药科大学作者 |
来源期刊 |
学 科 |
被引频次 |
出版年 |
1 |
THE PI3K/AKT PATHWAY IN OBESITY AND TYPE 2 DIABETES |
苏政权（通讯作者） |
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 14 (11): 1483-1496 2018 |
BIOLOGY & BIOCHEMISTRY |
1195 |
2018 |
2 |
GEMCITABINE AND CISPLATIN INDUCTION CHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA |
王希成（第十四作者） |
NEW ENGLAND JOURNAL OF MEDICINE 381 (12): 1124-1135 SEP 19 2019 |
CLINICAL MEDICINE |
690 |
2019 |
3 |
M2B MACROPHAGE POLARIZATION AND ITS ROLES IN DISEASES |
郭姣（通讯作者） |
JOURNAL OF LEUKOCYTE BIOLOGY 106 (2): 345-358 AUG 2019 |
IMMUNOLOGY |
676 |
2019 |
4 |
ASSOCIATION OF BLOOD GLUCOSE CONTROL AND OUTCOMES IN PATIENTS WITH COVID-19 AND PRE-EXISTING TYPE 2 DIABETES |
郭姣（通讯作者） |
CELL METABOLISM 31 (6): 1068-+ JUN 2 2020 |
MOLECULAR BIOLOGY & GENETICS |
666 |
2020 |
5 |
NETWORK PHARMACOLOGY IN RESEARCH OF CHINESE MEDICINE FORMULA: METHODOLOGY, APPLICATION AND PROSPECTIVE |
郭姣（通讯作者） |
CHINESE JOURNAL OF INTEGRATIVE MEDICINE 26 (1): 72-80 JAN 2020 |
CLINICAL MEDICINE |
524 |
2020 |
6 |
ADIPOCYTE-SECRETED EXOSOMAL MICRORNA-34A INHIBITS M2 MACROPHAGE POLARIZATION TO PROMOTE OBESITY-INDUCED ADIPOSE INFLAMMATION |
叶得伟（第四作者） |
JOURNAL OF CLINICAL INVESTIGATION 129 (2): 834-849 FEB 1 2019 |
CLINICAL MEDICINE |
371 |
2019 |
7 |
EFFECT OF FIRST-LINE SERPLULIMAB VS PLACEBO ADDED TO CHEMOTHERAPY ON SURVIVAL IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER THE ASTRUM-005 RANDOMIZED CLINICAL TRIAL |
王希成（第十二作者） |
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 328 (12): 1223-1232 SEP 27 2022 |
CLINICAL MEDICINE |
361 |
2022 |
8 |
IN-HOSPITAL USE OF STATINS IS ASSOCIATED WITH A REDUCED RISK OF MORTALITY AMONG INDIVIDUALS WITH COVID-19 |
郭姣（通讯作者） |
CELL METABOLISM 32 (2): 176-+ AUG 4 2020 |
MOLECULAR BIOLOGY & GENETICS |
345 |
2020 |
9 |
UNDERESTIMATED HEALTH RISKS: POLYSTYRENE MICRO- AND NANOPLASTICS JOINTLY INDUCE INTESTINAL BARRIER DYSFUNCTION BY ROS-MEDIATED EPITHELIAL CELL APOPTOSIS |
江俊莹（学生，第八作者） |
PARTICLE AND FIBRE TOXICOLOGY 18 (1): - JUN 7 2021 |
PHARMACOLOGY & TOXICOLOGY |
321 |
2021 |
10 |
RESEARCH PROGRESS ON BERBERINE WITH A SPECIAL FOCUS ON ITS ORAL BIOAVAILABILITY |
龙晓英（通讯作者） |
FITOTERAPIA 109: 274-282 MAR 2016 |
PHARMACOLOGY & TOXICOLOGY |
283 |
2016 |
11 |
RESVERATROL ENCAPSULATION IN CORE-SHELL BIOPOLYMER NANOPARTICLES: IMPACT ON ANTIOXIDANT AND ANTICANCER ACTIVITIES |
胡坤（通讯作者） |
FOOD HYDROCOLLOIDS 64: 157-165 MAR 2017 |
AGRICULTURAL SCIENCES |
262 |
2017 |
12 |
A COMPOSITE HYDROGEL WITH CO-DELIVERY OF ANTIMICROBIAL PEPTIDES AND PLATELET-RICH PLASMA TO ENHANCE HEALING OF INFECTED WOUNDS IN DIABETES |
姚泽欣（学生，第三作者） |
ACTA BIOMATERIALIA 124: 205-218 APR 1 2021 |
MATERIALS SCIENCE |
243 |
2021 |
13 |
PANCREATIC CANCER: A REVIEW OF RISK FACTORS, DIAGNOSIS, AND TREATMENT |
刘伟（通讯作者） |
TECHNOLOGY IN CANCER RESEARCH & TREATMENT 19: - DEC 23 2020 |
CLINICAL MEDICINE |
222 |
2020 |
14 |
TNF ANTAGONIST SENSITIZES SYNOVIAL FIBROBLASTS TO FERROPTOTIC CELL DEATH IN COLLAGEN-INDUCED ARTHRITIS MOUSE MODELS |
秦艺菲（学生，第十作者） |
NATURE COMMUNICATIONS 13 (1): - FEB 3 2022 |
CLINICAL MEDICINE |
216 |
2022 |
15 |
ENHANCEMENT OF CURCUMIN WATER DISPERSIBILITY AND ANTIOXIDANT ACTIVITY USING CORE-SHELL PROTEIN-POLYSACCHARIDE NANOPARTICLES |
胡坤（通讯作者） |
FOOD RESEARCH INTERNATIONAL 87: 1-9 SEP 2016 |
AGRICULTURAL SCIENCES |
198 |
2016 |
16 |
DUBOSIELLA NEWYORKENSIS MODULATES IMMUNE TOLERANCE IN COLITIS VIA THE L-LYSINE-ACTIVATED AHR-IDO1-KYN PATHWAY |
涂舒谕（学生，第二作者） |
NATURE COMMUNICATIONS 15 (1): - FEB 13 2024 |
IMMUNOLOGY |
195 |
2024 |
17 |
BAICALIN PREVENTS LPS-INDUCED ACTIVATION OF TLR4/NF-?B P65 PATHWAY AND INFLAMMATION IN MICE VIA INHIBITING THE EXPRESSION OF CD14 |
邓向亮(通讯作者) |
ACTA PHARMACOLOGICA SINICA 42 (1): 88-96 JAN 2021 |
PHARMACOLOGY & TOXICOLOGY |
193 |
2021 |
18 |
ENCAPSULATION OF RESVERATROL IN ZEIN/PECTIN CORE-SHELL NANOPARTICLES: STABILITY, BIOACCESSIBILITY, AND ANTIOXIDANT CAPACITY AFTER SIMULATED GASTROINTESTINAL DIGESTION |
胡坤（通讯作者） |
FOOD HYDROCOLLOIDS 93: 261-269 AUG 2019 |
AGRICULTURAL SCIENCES |
192 |
2019 |
19 |
PREVENTION AND TREATMENT OF COVID-19 USING TRADITIONAL CHINESE MEDICINE: A REVIEW |
周良云（第三作者） |
PHYTOMEDICINE 85: - MAY 2021 |
PHARMACOLOGY & TOXICOLOGY |
171 |
2021 |
20 |
EFFECT OF FECAL MICROBIOTA TRANSPLANTATION ON NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CLINICAL TRIAL |
何兴祥（通讯作者） |
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 12: - JUL 4 2022 |
MICROBIOLOGY |
162 |
2022 |
21 |
METRONOMIC CAPECITABINE AS ADJUVANT THERAPY IN LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA: A MULTICENTRE, OPEN-LABEL, PARALLEL-GROUP, RANDOMISED, CONTROLLED, PHASE 3 TRIAL |
王希成（第十七作者） |
LANCET 398 (10297): 303-313 JUL 24 2021 |
CLINICAL MEDICINE |
160 |
2021 |
22 |
DRUG AFFINITY RESPONSIVE TARGET STABILITY (DARTS) ACCELERATED SMALL MOLECULES TARGET DISCOVERY: PRINCIPLES AND APPLICATION |
葛跃伟(通讯作者) |
BIOCHEMICAL PHARMACOLOGY 194: - DEC 2021 |
PHARMACOLOGY & TOXICOLOGY |
154 |
2021 |
23 |
DRUG-MICROBIOTA INTERACTIONS: AN EMERGING PRIORITY FOR PRECISION MEDICINE |
张威（通讯作者） |
SIGNAL TRANSDUCTION AND TARGETED THERAPY 8 (1): - OCT 9 2023 |
MOLECULAR BIOLOGY & GENETICS |
150 |
2023 |
24 |
CORDYCEPIN AMELIORATES NONALCOHOLIC STEATOHEPATITIS BY ACTIVATION OF THE AMP-ACTIVATED PROTEIN KINASE SIGNALING PATHWAY |
郭姣（通讯作者） |
HEPATOLOGY 74 (2): 686-703 AUG 2021 |
CLINICAL MEDICINE |
145 |
2021 |
25 |
EF24 INDUCES FERROPTOSIS IN OSTEOSARCOMA CELLS THROUGH HMOX1 |
林绍强（通讯作者） |
BIOMEDICINE & PHARMACOTHERAPY 136: - APR 2021 |
PHARMACOLOGY & TOXICOLOGY |
144 |
2021 |
26 |
TORIPALIMAB PLUS CHEMOTHERAPY FOR PATIENTS WITH TREATMENT-NAIVE ADVANCED NON-SMALL-CELL LUNG CANCER: A MULTICENTER RANDOMIZED PHASE III TRIAL (CHOICE-01) |
王希成（第六作者） |
JOURNAL OF CLINICAL ONCOLOGY 41 (3): 651-+ JAN 20 2023 |
CLINICAL MEDICINE |
142 |
2023 |
27 |
ADIPOCYTE-DERIVED LACTATE IS A SIGNALLING METABOLITE THAT POTENTIATES ADIPOSE MACROPHAGE INFLAMMATION VIA TARGETING PHD2 |
叶德伟（第十五作者） |
NATURE COMMUNICATIONS 13 (1): - SEP 5 2022 |
CLINICAL MEDICINE |
131 |
2022 |
28 |
UNVEILING THE THERAPEUTIC SYMPHONY OF PROBIOTICS, PREBIOTICS, AND POSTBIOTICS IN GUT-IMMUNE HARMONY |
周朋君（第一作者） |
FRONTIERS IN NUTRITION 11: - FEB 8 2024 |
CLINICAL MEDICINE |
114 |
2024 |
29 |
FINAL OVERALL SURVIVAL ANALYSIS OF GEMCITABINE AND CISPLATIN INDUCTION CHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA: A MULTICENTER, RANDOMIZED PHASE III TRIAL |
王希成（第十四作者） |
JOURNAL OF CLINICAL ONCOLOGY 40 (22): 2420-+ AUG 1 2022 |
CLINICAL MEDICINE |
110 |
2022 |
30 |
FERROPTOSIS: EMERGING MECHANISMS, BIOLOGICAL FUNCTION, AND THERAPEUTIC POTENTIAL IN CANCER AND INFLAMMATION |
朱金容(通讯作者) |
CELL DEATH DISCOVERY 10 (1): - JAN 24 2024 |
MOLECULAR BIOLOGY & GENETICS |
105 |
2024 |
31 |
ASSOCIATION OF THE WEEKEND WARRIOR AND OTHER LEISURE-TIME PHYSICAL ACTIVITY PATTERNS WITH ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY A NATIONWIDE COHORT STUDY |
Huang, Wentao（第七作者） |
JAMA INTERNAL MEDICINE 182 (8): 840-848 AUG 2022 |
CLINICAL MEDICINE |
102 |
2022 |
32 |
MULTIMODAL CELL ATLAS OF THE AGEING HUMAN SKELETAL MUSCLE |
宋炎成（第十九作者） |
NATURE 629 (8010): 154-+ MAY 2 2024 |
MOLECULAR BIOLOGY & GENETICS |
102 |
2024 |
33 |
LUTEOLIN: A PROMISING MULTIFUNCTIONAL NATURAL FLAVONOID FOR HUMAN DISEASES |
王秋红(通讯作者) |
PHYTOTHERAPY RESEARCH 38 (7): 3417-3443 JUL 2024 |
PHARMACOLOGY & TOXICOLOGY |
101 |
2024 |
34 |
LIBERATION OF DAIDZEIN BY GUT MICROBIAL β-GALACTOSIDASE SUPPRESSES ACETAMINOPHEN-INDUCED HEPATOTOXICITY IN MICE |
覃萍（学生，第七作者） |
CELL HOST & MICROBE 31 (5): 766-+ MAY 10 2023 |
MICROBIOLOGY |
95 |
2023 |
35 |
PREGNANCY-INDUCED CHANGES TO THE GUT MICROBIOTA DRIVE MACROPHAGE PYROPTOSIS AND EXACERBATE SEPTIC INFLAMMATION |
陈阿丽（第十二作者） |
IMMUNITY 56 (2): 336-+ FEB 14 2023 |
IMMUNOLOGY |
93 |
2023 |
36 |
IMMUNE CHECKPOINT INHIBITORS: BREAKTHROUGHS IN CANCER TREATMENT |
张荣信(通讯作者) |
CANCER BIOLOGY & MEDICINE 21 (6): 451-472 JUN 15 2024 |
CLINICAL MEDICINE |
82 |
2024 |
37 |
RUTIN AMELIORATED LIPID METABOLISM DYSFUNCTION OF DIABETIC NAFLD VIA AMPK/SREBP1 PATHWAY |
王艺霖（第十作者） |
PHYTOMEDICINE 126: - APR 2024 |
PHARMACOLOGY & TOXICOLOGY |
81 |
2024 |
38 |
KAEMPFEROL PREVENTS ACETAMINOPHEN-INDUCED LIVER INJURY BY SUPPRESSING HEPATOCYTE FERROPTOSIS VIA NRF2 PATHWAY ACTIVATION |
兰天（通讯作者） |
FOOD & FUNCTION 14 (4): 1884-1896 FEB 21 2023 |
AGRICULTURAL SCIENCES |
77 |
2023 |
39 |
SEPSIS BIOMARKERS: ADVANCEMENTS AND CLINICAL APPLICATIONS-A NARRATIVE REVIEW |
Cheng, Chen（通讯作者） |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 25 (16): - AUG 2024 |
CHEMISTRY |
73 |
2024 |
40 |
MECHANISM OF ACTION OF THE BILE ACID RECEPTOR TGR5 IN OBESITY |
苏政权（通讯作者） |
ACTA PHARMACEUTICA SINICA B 14 (2): 468-491 FEB 2024 |
PHARMACOLOGY & TOXICOLOGY |
64 |
2024 |
41 |
INFLAMMATION TRIGGERS CHONDROCYTE FERROPTOSIS IN TMJOA VIA HIF-1Α/TFRC |
Wang, L. J.（第七作者） |
JOURNAL OF DENTAL RESEARCH 103 (7): 712-722 JUL 2024 |
CLINICAL MEDICINE |
52 |
2024 |
42 |
ICARITIN WITH AUTOPHAGY/MITOPHAGY INHIBITORS SYNERGISTICALLY ENHANCES ANTICANCER EFFICACY AND APOPTOTIC EFFECTS THROUGH PINK1/PARKIN-MEDIATED MITOPHAGY IN HEPATOCELLULAR CARCINOMA |
肖炜（通讯作者） |
CANCER LETTERS 587: - APR 10 2024 |
CLINICAL MEDICINE |
50 |
2024 |
43 |
SELECTIVE UTILIZATION OF MEDICINAL POLYSACCHARIDES BY HUMAN GUT BACTEROIDES AND PARABACTEROIDES SPECIES |
杨继（学生，第三作者） |
NATURE COMMUNICATIONS 16 (1): - JAN 14 2025 |
BIOLOGY & BIOCHEMISTRY |
45 |
2025 |
44 |
INTEGRATING NETWORK PHARMACOLOGY AND ANIMAL EXPERIMENTAL VALIDATION TO INVESTIGATE THE ACTION MECHANISM OF OLEANOLIC ACID IN OBESITY |
胡旭光(通讯作者) |
JOURNAL OF TRANSLATIONAL MEDICINE 22 (1): - JAN 21 2024 |
CLINICAL MEDICINE |
44 |
2024 |
45 |
TRIPTOLIDE INDUCES APOPTOSIS AND CYTOPROTECTIVE AUTOPHAGY BY ROS ACCUMULATION VIA DIRECTLY TARGETING PEROXIREDOXIN 2 IN GASTRIC CANCER CELLS |
杨文岳（学生，第九作者） |
CANCER LETTERS 587: - APR 10 2024 |
CLINICAL MEDICINE |
42 |
2024 |
46 |
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS REVEALS GUT MICROBIOTA-IMMUNOTHERAPY SYNERGY THROUGH MODULATING TUMOR MICROENVIRONMENT |
张威（第二十五作者) |
SIGNAL TRANSDUCTION AND TARGETED THERAPY 10 (1): - MAY 2 2025 |
MOLECULAR BIOLOGY & GENETICS |
35 |
2025 |
47 |
ISOQUERCITRIN ALLEVIATES DIABETIC NEPHROPATHY BY INHIBITING STAT3 PHOSPHORYLATION AND DIMERIZATION |
Chen, Donghui（第二作者） |
ADVANCED SCIENCE 12 (25): - JUL 2025 |
PHYSICS |
27 |
2025 |
48 |
EPIGENETIC REGULATORY MECHANISM OF MACROPHAGE POLARIZATION IN DIABETIC WOUND HEALING (REVIEW) |
Wu, Yuqing（第二作者） |
MOLECULAR MEDICINE REPORTS 31 (1): - JAN 2025 |
CLINICAL MEDICINE |
18 |
2025 |
49 |
TALETRECTINIB IN ROS1+ NON-SMALL CELL LUNG CANCER: TRUST |
王希成（第十三作者） |
JOURNAL OF CLINICAL ONCOLOGY 43 (16): - JUN 1 2025 |
CLINICAL MEDICINE |
18 |
2025 |
50 |
POLYSACCHARIDE-BASED HIGH BARRIER FOOD PACKAGING FILM: DESIGN AND APPLICATION |
黎珊珊(通讯作者) |
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 65 (31): 7651-7670 NOV 20 2025 |
AGRICULTURAL SCIENCES |
18 |
2025 |
51 |
ULTRASOUND-ACTIVATED ERYTHROCYTE MEMBRANE-CAMOUFLAGED PT (II) LAYERED DOUBLE HYDROXIDE ENHANCES PD-1 INHIBITOR EFFICACY IN TRIPLE-NEGATIVE BREAST CANCER THROUGH CGAS-STING PATHWAY-MEDIATED IMMUNOGENIC CELL DEATH |
Liu, Wei（第五作者） |
THERANOSTICS 15 (4): 1456-1477 2025 |
CLINICAL MEDICINE |
16 |
2025 |
52 |
TARGETING THE ADENOSINE-MEDIATED METABOLIC IMMUNE CHECKPOINT WITH ENGINEERED PROBIOTIC FOR ENHANCED CHEMO-IMMUNOTHERAPY |
Yu, Zhijie（第五作者） |
ADVANCED SCIENCE 12 (15): - APR 2025 |
PHYSICS |
16 |
2025 |
53 |
ATGL REGULATES RENAL FIBROSIS BY REPROGRAMMING LIPID METABOLISM DURING THE TRANSITION FROM AKI TO CKD |
夏纪凯（第五作者） |
MOLECULAR THERAPY 33 (2): 805-822 FEB 5 2025 |
CLINICAL MEDICINE |
15 |
2025 |
54 |
ASSOCIATION BETWEEN THE CHANGES IN THE ESTIMATED GLUCOSE DISPOSAL RATE AND NEW-ONSET CARDIOVASCULAR DISEASE IN MIDDLE-AGED AND ELDERLY INDIVIDUALS: A NATIONWIDE PROSPECTIVE COHORT STUDY IN CHINA |
罗丽芳（第六作者） |
DIABETES OBESITY & METABOLISM 27 (4): 1859-1867 APR 2025 |
CLINICAL MEDICINE |
10 |
2025 |
